Routine medication use, as-needed medication use and psychotherapeutic medication usage across nursing facilities will be evaluated in a study sponsored by the American Society of Consultant Pharmacists' Research and Education Foundation, Alexandria, VA.
Routine medication use, as-needed medication use and psychotherapeutic medication usage across nursing facilities will be evaluated in a study sponsored by the American Society of Consultant Pharmacists' Research and Education Foundation, Alexandria, VA.
The 1997 National Medication Usage Study, the third of its kind, will update findings from the most recent investigation in 1994, according to Janice Feinberg, executive director of the society's research foundation.
Study coordinator Dianne Tobias, president of Tobias Consulting Services, Placentia, CA, will interpret medication use data submitted last month by Canadian and U.S. nursing facilities and consultant pharmacists.
At press time, nursing facilities and consultant pharmacists were scheduled to receive their usage statistics and regional and national averages by May 31.
The society will release its findings later this year.
According to the society, the data analysis will help long-term care pharmacists strategize consulting, provide facilities with comparative data useful for continuous quality improvement and allow providers to benchmark individual practices.
"The study will help facilities, pharmacists and physicians do an apples-to-apples comparison of their data [compared with] other facilities," said Tobias. It will also stimulate other facilities that did not participate in the study to review and assess the appropriateness of their medication use, she said.
The study's findings will be particularly useful for facilities operating as part of a managed care network, Tobias said.
"If a facility or consultant pharmacist is paid under capitation, it will be to everyone's benefit to use fewer drugs," she said.
"Capitation creates an incentive to optimize as well as minimize drug use on both the provider and patient side," Tobias said. PR
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.